538 related articles for article (PubMed ID: 30362065)
1. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
2. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
[TBL] [Abstract][Full Text] [Related]
3. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
4. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
[TBL] [Abstract][Full Text] [Related]
5. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
[TBL] [Abstract][Full Text] [Related]
7. Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective Study.
Harinath L; Villatoro TM; Clark BZ; Fine JL; Yu J; Carter GJ; Diego E; McAuliffe PF; Mai P; Lu A; Zuley M; Berg WA; Bhargava R
Mod Pathol; 2024 Apr; 37(4):100462. PubMed ID: 38428736
[TBL] [Abstract][Full Text] [Related]
8. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
[TBL] [Abstract][Full Text] [Related]
10. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
11. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.
Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ
Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416
[TBL] [Abstract][Full Text] [Related]
12. Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target.
D'Alfonso TM; Wang K; Chiu YL; Shin SJ
Arch Pathol Lab Med; 2013 Jul; 137(7):927-35. PubMed ID: 23808465
[TBL] [Abstract][Full Text] [Related]
13. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience.
Hoffman DI; Zhang PJ; Tchou J
Surg Oncol; 2019 Mar; 28():190-194. PubMed ID: 30851899
[TBL] [Abstract][Full Text] [Related]
14. Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
Lee J; Ku GY; Lee H; Park HS; Ku JS; Kim JY; Park S; Park BW
Cancer Res Treat; 2022 Oct; 54(4):1074-1080. PubMed ID: 34942684
[TBL] [Abstract][Full Text] [Related]
15. Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ.
Pride RM; Jimenez RE; Hoskin TL; Degnim AC; Hieken TJ
Surgery; 2021 Mar; 169(3):644-648. PubMed ID: 32861439
[TBL] [Abstract][Full Text] [Related]
16. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
Mahoney MC; Robinson-Smith TM; Shaughnessy EA
AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
[TBL] [Abstract][Full Text] [Related]
17. Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
Susnik B; Day D; Abeln E; Bowman T; Krueger J; Swenson KK; Tsai ML; Bretzke ML; Lillemoe TJ
Clin Breast Cancer; 2016 Dec; 16(6):507-513. PubMed ID: 27425222
[TBL] [Abstract][Full Text] [Related]
18. Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on Breast Core Needle Biopsy: Is Surgical Excision Warranted?
Karimi Z; Phillips J; Brook A; Baker G; Guzman Y; Mehta TS
Acad Radiol; 2022 Jul; 29(7):1029-1038. PubMed ID: 34702673
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
[TBL] [Abstract][Full Text] [Related]
20. Observation versus excision of lobular neoplasia on core needle biopsy of the breast.
Schmidt H; Arditi B; Wooster M; Weltz C; Margolies L; Bleiweiss I; Port E; Jaffer S
Breast Cancer Res Treat; 2018 Apr; 168(3):649-654. PubMed ID: 29299726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
